Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate
2002-12-17
2008-08-12
Tucker, Zachary C (Department: 1624)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
C544S405000
Reexamination Certificate
active
07410972
ABSTRACT:
The invention provides N-pyrazinyl-thienylsulphonamides of formula (I) for use in the treatment of chemokine mediated diseases. Particularly inflammatory diseases, such as asthma
REFERENCES:
patent: 5962490 (1999-10-01), Chan et al.
patent: 6420567 (2002-07-01), Wu et al.
patent: 6632829 (2003-10-01), Wu et al.
patent: 0713875 (1996-05-01), None
patent: 98/13366 (1998-04-01), None
patent: 2004/007472 (2004-01-01), None
Vippagunta et al, “Crystalline Solids” Advanced Drug Delivery Reviews, vol. 48, pp. 3-26 (2001).
Gavezzotti, “Are Crystal Structures Predictable?” Accounts of Chemical Research, vol. 27, pp. 309-314 (1994).
Chantry and Burgess, “Chemokines in Allergy” Current Drug Topics—Inflammation & Allergy, vol. 1, pp. 109-116 (2002).
Baxter Andrew
Johnson Timothy
Kindon Nicholas
Roberts Bryan
Steele John
AstraZeneca AB
Morgan & Lewis & Bockius, LLP
Tucker Zachary C
LandOfFree
Compounds does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Compounds, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Compounds will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4009935